Skip to main content
. 2019 Jan 22;41(3):1539–1548. doi: 10.3892/or.2019.6977

Figure 4.

Figure 4.

PRDX2 silencing in HCCLM3 cell line. (A and B) PRDX2 silencing in HCCLM3 cells. A t-test was used to compare the difference between groups, *P<0.05 compared to HCCLM3-NC. (C) PRDX2 silencing in HCCLM3 cells promoted cancer cell migration ability. A t-test was used to compare the difference between groups; *P<0.05 compared to HCCLM3-NC. (D) PRDX2 silencing in HCCLM3 cells promoted cancer cell proliferation ability. At-test was used to compare the difference between groups; *P<0.05 compared to HCCLM3-NC. PRDX2, peroxiredoxin2.